The solution to this problem, which is widely recognized, is the generation of small molecule, blood-brain-barrier (BBB) permeable drugs that act as mimetics of pertinent neurotrophic factors
Injectable healing protocol: Dose: 2-3mg daily (higher end of range) Frequency: Daily throughout healing period Duration: Until wound resolves plus 1-2 weeks Injection site: Systemic (not into wound) Topical healing protocol: Concentration: 2-4% in wound-appropriate vehicle Application: 2-3 times daily to wound margins (not directly into open wounds) Duration: Throughout healing process Note: Consult healthcare provider for significant wounds GHK-CU pairs exceptionally well with BPC-157 and TB-500 for wound healing
Compounded GLP-1s for weight loss, such as compounded semaglutide and compounded tirzepatide, boomed in popularity over the past few years during shortages of name-brand GLP-1s
Telomerase is the enzyme that can add nucleotides back to telomeres, potentially extending cellular replicative lifespan
Therefore, no company has officially initiated the NDA approval process for GHK-Cu
This makes it easy to see when you are at peak levels, when the trough occurs, and how shifting your injection day or time would change the curve
